Clover Health Investments Stock Performance
| CLOV Stock | USD 2.94 0.07 2.33% |
The firm shows a Beta (market volatility) of 0.92, which signifies possible diversification benefits within a given portfolio. Clover Health returns are very sensitive to returns on the market. As the market goes up or down, Clover Health is expected to follow. At this point, Clover Health Investments has a negative expected return of -0.14%. Please make sure to confirm Clover Health's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Clover Health Investments performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Clover Health Investments has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
Actual Historical Performance (%)
One Day Return (2.33) | Five Day Return 0.68 | Year To Date Return (6.07) | Ten Year Return (71.18) | All Time Return (71.18) |
1 | Disposition of 825989 shares by Peter Kuipers of Clover Health at 3.45 subject to Rule 16b-3 | 04/29/2025 |
2 | Disposition of 25080 shares by Priest Brady Patrick of Clover Health at 3.4 subject to Rule 16b-3 | 04/30/2025 |
3 | Clover Health Q1 Earnings What To Expect | 05/05/2025 |
4 | Clover Health Investments, Corp.s market cap rose US220m last week individual investors who hold 59 percent profited and so did insiders | 05/09/2025 |
5 | Acquisition by Tran Thomas L of 60975 shares of Clover Health subject to Rule 16b-3 | 05/20/2025 |
6 | Heres Why You Should Hold Cigna Stock in Your Portfolio for Now - TradingView | 06/02/2025 |
7 | Disposition of 8691 shares by Jamie Reynoso of Clover Health at 2.89 subject to Rule 16b-3 | 06/13/2025 |
8 | Disposition of 20450 shares by Jamie Reynoso of Clover Health at 2.86 subject to Rule 16b-3 | 06/17/2025 |
9 | Disposition of 12567 shares by Jamie Reynoso of Clover Health at 2.89 subject to Rule 16b-3 | 06/18/2025 |
10 | Clover Health Set to Join Russell 3000 Index | 06/30/2025 |
11 | Disposition of 308950 shares by Andrew Toy of Clover Health at 2.75 subject to Rule 16b-3 | 07/01/2025 |
12 | Disposition of 8706 shares by Jamie Reynoso of Clover Health at 2.56 subject to Rule 16b-3 | 07/03/2025 |
13 | Craig-Hallum Reiterates a Buy Rating on Clover Health Investments , Sets a 6 PT | 07/07/2025 |
14 | Whats Going On With Clover Health Stock | 07/08/2025 |
15 | Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPCs iCare Network | 07/09/2025 |
16 | Clover Health Investments Announces Launch of a New Community-Based Pharmacy Pilot Program across New Jersey | 07/11/2025 |
17 | Clover Health Investments Corp Appoints New Vice President of Finance and Controller ... | 07/17/2025 |
| Begin Period Cash Flow | 176.5 M | |
| Total Cashflows From Investing Activities | 565 K |
Clover Health Relative Risk vs. Return Landscape
If you would invest 332.00 in Clover Health Investments on April 20, 2025 and sell it today you would lose (38.00) from holding Clover Health Investments or give up 11.45% of portfolio value over 90 days. Clover Health Investments is currently does not generate positive expected returns and assumes 3.5336% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Clover, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Clover Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clover Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Clover Health Investments, and traders can use it to determine the average amount a Clover Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0385
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLOV |
Estimated Market Risk
| 3.53 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Clover Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clover Health by adding Clover Health to a well-diversified portfolio.
Clover Health Fundamentals Growth
Clover Stock prices reflect investors' perceptions of the future prospects and financial health of Clover Health, and Clover Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clover Stock performance.
| Return On Equity | -0.0775 | ||||
| Return On Asset | -0.0243 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 416.54 M | ||||
| Price To Book | 4.45 X | ||||
| Price To Sales | 1.03 X | ||||
| Revenue | 1.37 B | ||||
| Gross Profit | 391.93 M | ||||
| EBITDA | (44.94 M) | ||||
| Net Income | (43.01 M) | ||||
| Cash And Equivalents | 711.78 M | ||||
| Cash Per Share | 1.49 X | ||||
| Total Debt | 239.6 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 0.66 X | ||||
| Cash Flow From Operations | 34.84 M | ||||
| Earnings Per Share | (0.04) X | ||||
| Market Capitalization | 1.53 B | ||||
| Total Asset | 580.74 M | ||||
| Retained Earnings | (2.2 B) | ||||
| Working Capital | 129.61 M | ||||
About Clover Health Performance
Evaluating Clover Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Clover Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clover Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (33.70) | (35.39) | |
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Capital Employed | (0.12) | (0.12) | |
| Return On Assets | (0.07) | (0.08) | |
| Return On Equity | (0.13) | (0.12) |
Things to note about Clover Health Investments performance evaluation
Checking the ongoing alerts about Clover Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clover Health Investments help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clover Health generated a negative expected return over the last 90 days | |
| Clover Health has high historical volatility and very poor performance | |
| Clover Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.37 B. Net Loss for the year was (43.01 M) with profit before overhead, payroll, taxes, and interest of 391.93 M. | |
| Latest headline from gurufocus.com: Amazon and CrowdStrike Partner to Enhance AI in Cybersecurity AMZN Stock News |
- Analyzing Clover Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clover Health's stock is overvalued or undervalued compared to its peers.
- Examining Clover Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clover Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clover Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clover Health's stock. These opinions can provide insight into Clover Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Clover Stock Analysis
When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.